Neurobiological Mechanisms of Addiction

Addiction arises from maladaptive adaptations in brain circuits that underlie learning, motivation and stress responses. Central to these adaptations is the mesolimbic dopamine pathway, in which neurons originating in the ventral tegmental area (VTA) project to the nucleus accumbens (NAc) and prefrontal cortex to encode reward and guide goal-directed behaviour. Chronic exposure to addictive substances or behaviours alters synaptic strength, gene expression and neuronal excitability across multiple cell types—including dopaminergic, GABAergic and glutamatergic populations—and across interconnected regions such as the amygdala and dorsal striatum. These neuroplastic changes shift control from voluntary, goal-directed actions to habitual, compulsive behaviour and enhance sensitivity to drug-associated cues. Emerging evidence highlights cell-type-specific gene regulatory programmes and sex differences in circuit function, and points to the interplay of positive and negative reinforcement in driving continued use and relapse. Understanding these mechanisms is crucial for developing targeted interventions to restore healthy network function and reduce the global burden of substance use disorders.

Research from Nature Portfolio

Recent studies have delineated the neuronal ensembles that mediate opposing reinforcement processes in opioid addiction, showing that discrete µ-opioid receptor–expressing populations in the VTA trigger dopamine-dependent positive reinforcement, whereas a separate population in the central amygdala drives aversive withdrawal and negative reinforcement. In the context of stimulant addiction, single-nucleus transcriptomics and chromatin accessibility profiling in the amygdala of outbred rats with divergent cocaine-seeking behaviour have revealed cell-type-specific upregulation of energy-metabolism genes and enhanced GABAergic transmission that underpins relapse-like phenotypes, reversible by targeting a metabolic enzyme. Complementing these rodent findings, single-nucleus RNA sequencing of human and non-human primate dorsal striatum in opioid use disorder has uncovered neuron-specific signatures of DNA damage, neuroinflammation pathways and sex-dependent glial alterations, offering a detailed atlas of transcriptional vulnerability in chronic opioid exposure.

Neurobiological Mechanisms of Addiction publication trend

The graph below shows the total number of articles in neurobiological mechanisms of addiction across all publications each year (not limited to Nature Index journals).

Technical terms

Positive reinforcement: Strengthening of behaviour by presentation of a rewarding stimulus.

Negative reinforcement: Strengthening of behaviour by removal of an aversive state.

Mesolimbic dopamine pathway: Neural circuit from the ventral tegmental area to the nucleus accumbens that encodes reward and motivation.

Medium spiny neurons: Principal GABAergic projection neurons of the striatum that integrate excitatory and modulatory inputs.

Chromatin accessibility: Degree to which DNA is exposed for transcription factor binding, reflecting gene regulatory potential.

Single-nucleus RNA sequencing: High-resolution method to profile gene expression in individual nuclei from complex tissues.

References

1. Distinct µ-opioid ensembles trigger positive and negative fentanyl reinforcement. Nature (2024).
2. Single-nucleus genomics in outbred rats with divergent cocaine addiction-like behaviors reveals changes in amygdala GABAergic inhibition. Nature Neuroscience (2023).
3. Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder. Nature Communications (2024).
4. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience (2008).
5. Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories – indications for novel treatments of addiction. European Journal of Neuroscience (2014).
6. Nucleus accumbens medium spiny neurons subtypes signal both reward and aversion. Molecular Psychiatry (2019).